APA (7th ed.) Citation

AS, M., JI, G., CE, A., N, S., E, S., EL, D., . . . PR, L. (2018). Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer. Pharmaceutical research, 35(2), 31. https://doi.org/10.1007/s11095-017-2278-0

Chicago Style (17th ed.) Citation

AS, Mohammad, et al. "Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer." Pharmaceutical Research 35, no. 2 (2018): 31. https://doi.org/10.1007/s11095-017-2278-0.

MLA (9th ed.) Citation

AS, Mohammad, et al. "Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer." Pharmaceutical Research, vol. 35, no. 2, 2018, p. 31, https://doi.org/10.1007/s11095-017-2278-0.